Veli-Matti Kähäri Selected Research

Veli-Matti Kähäri Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 01/2002
22	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2002
14	Neoplasm Metastasis (Metastasis) 11/2021 - 02/2002
11	Melanoma (Melanoma, Malignant) 02/2021 - 02/2002
5	Inflammation (Inflammations) 01/2021 - 01/2013
5	Skin Neoplasms (Skin Cancer) 11/2018 - 03/2003
4	Actinic Keratosis 09/2020 - 02/2015
4	Carcinogenesis 01/2017 - 06/2002
4	Wounds and Injuries (Trauma) 10/2015 - 03/2003
3	Carcinoma (Carcinomatosis) 01/2021 - 08/2010
3	Fibrosis (Cirrhosis) 01/2013 - 05/2008
3	Salivary Gland Neoplasms (Salivary Gland Cancer) 08/2010 - 04/2008
2	Basal Cell Carcinoma (Rodent Ulcer) 09/2020 - 06/2009
2	Seborrheic Keratosis 01/2020 - 02/2015
2	Papilloma (Papillomatosis) 05/2017 - 02/2015
2	Hypoxia (Hypoxemia) 07/2010 - 02/2010
2	Squamous Cell Carcinoma of Head and Neck 04/2010 - 03/2006
2	Head and Neck Neoplasms (Head and Neck Cancer) 03/2006 - 03/2003
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Bowen's Disease (Disease, Bowen) 01/2017
1	Myoma 01/2017
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 02/2015
1	Breast Neoplasms (Breast Cancer) 02/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2011
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2011
1	Experimental Liver Cirrhosis 01/2011
1	Infections 10/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2009
1	Skin Ulcer 01/2007

Drug/Important Bio-Agent (IBA)

18	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2002
10	Matrix Metalloproteinase 13IBA 01/2022 - 01/2002
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2011
7	Messenger RNA (mRNA)IBA 01/2022 - 10/2002
6	Proteins (Proteins, Gene)FDA Link 09/2021 - 01/2003
5	CollagenIBA 01/2022 - 01/2007
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 09/2008
5	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 03/2003
4	Biological ProductsIBA 02/2021 - 02/2002
4	IntegrinsIBA 11/2018 - 10/2004
4	Tissue Inhibitor of Metalloproteinase-3IBA 01/2013 - 06/2002
4	Transforming Growth Factor beta (TGF-beta)IBA 07/2010 - 11/2007
3	chemotactic factor inactivatorIBA 11/2021 - 02/2015
3	Complement Factor I (C3b Inactivator)IBA 11/2021 - 02/2015
3	Metalloproteases (Metalloproteinases)IBA 11/2021 - 09/2008
3	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 07/2007
3	Complementary DNA (cDNA)IBA 01/2021 - 01/2002
3	RNA (Ribonucleic Acid)IBA 01/2020 - 12/2005
3	Long Noncoding RNAIBA 01/2020 - 01/2016
3	Complement System Proteins (Complement)IBA 07/2019 - 01/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2020
2	Laminin (Merosin)IBA 01/2017 - 01/2016
2	Complement Factor H (Factor H)IBA 01/2016 - 02/2014
2	CytokinesIBA 08/2014 - 09/2008
2	ChemokinesIBA 08/2014 - 09/2008
2	Small Interfering RNA (siRNA)IBA 03/2014 - 07/2010
2	Death Domain ReceptorsIBA 02/2011 - 04/2003
2	Caspase 8 (Caspase-8)IBA 02/2011 - 04/2003
2	Caspase 3 (Caspase-3)IBA 10/2010 - 04/2003
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 08/2010 - 07/2005
2	Tissue Inhibitor of MetalloproteinasesIBA 04/2010 - 06/2002
2	Collagenases (Collagenase)FDA Link 11/2009 - 03/2005
2	collagenase 1IBA 07/2005 - 02/2002
2	Matrix Metalloproteinase InhibitorsIBA 05/2005 - 05/2002
2	matrix metalloproteinase 19IBA 11/2003 - 03/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2003 - 10/2002
1	Complement Factor D (Factor D)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2020
1	Isosorbide FDA Link 09/2020
1	NitratesIBA 09/2020
1	InflammasomesIBA 07/2017
1	Complement Factor B (Factor B)IBA 05/2017
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	Collagen Type XVIIIBA 01/2017
1	KalininIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 12/2016
1	Collagen Type XVIII (Type XVIII Collagen)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2014
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012
1	Fibroblast Growth Factor 7 FDA Link 01/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2011
1	SerpinsIBA 09/2011
1	SuspensionsIBA 02/2011
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2011
1	Factor X (Stuart Factor)IBA 10/2010
1	Annexin A5IBA 10/2010
1	Antineoplastic Agents (Antineoplastics)IBA 10/2010
1	Urocanic AcidIBA 10/2010
1	DisintegrinsIBA 04/2010
1	ThrombospondinsIBA 04/2010
1	Peptides (Polypeptides)IBA 11/2007
1	Vascular Endothelial Growth Factor CIBA 01/2007

Therapy/Procedure

6	Therapeutics 01/2021 - 06/2002
3	Drug Therapy (Chemotherapy) 01/2014 - 05/2005
1	Radiotherapy 03/2006